Volume 9, Number 8—August 2003
Research
Multidrug-Resistant Tuberculosis in HIV-Negative Patients, Buenos Aires, Argentina
Domingo Palmero*
, Viviana Ritacco†, Martha Ambroggi‡, Marcela Natiello‡, Lucía Barrera†, Lilian Capone‡, Alicia Dambrosi‡, Martha Di Lonardo‡, Nélida Isola‡, Susana Poggi‡, Marisa Vescovo‡, and Eduardo Abbate‡
, Viviana Ritacco†, Martha Ambroggi‡, Marcela Natiello‡, Lucía Barrera†, Lilian Capone‡, Alicia Dambrosi‡, Martha Di Lonardo‡, Nélida Isola‡, Susana Poggi‡, Marisa Vescovo‡, and Eduardo Abbate‡
Figure 3
Figure 3. Biennial number of initial multidrug-resistant tuberculosis cases among HIV-negative patients and restriction fragment length polymorphism findings. RFLP, restriction fragment length polymorphism.
Page created: December 22, 2010
Page updated: December 22, 2010
Page reviewed: December 22, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.